Periscope Capital’s Organogenesis Holdings ORGO Stock Holding History

Periscope Capital’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-674,800	Closed	-$6.84M	–	187
2018 Q3	$6.84M	Sell	674,800 -10,000	-1%	-$101K	1.3%	25
2018 Q2	$6.87M	Sell	684,800 -183,000	-21%	-$1.83M	1.46%	22
2018 Q1	$8.66M	Buy	867,800 +94,800	+12%	+$944K	2.02%	12
2017 Q4	$7.66M	Buy	773,000 +399,300	+107%	+$3.96M	1.89%	15
2017 Q3	$3.74M	Buy	373,700 +69,101	+23%	+$686K	1.27%	34
2017 Q2	$3M	Buy	304,599 +154,599	+103%	+$1.52M	1.12%	35
2017 Q1	$1.48M	Buy	+150,000	New	+$1.48M	0.6%	41

Periscope Capital's ORGO Position: Q4 2018 in Review

Periscope Capital sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 674,800 shares — an estimated $6.84M sold.

Periscope Capital first reported a position in ORGO in Q1 2017 and held it in 7 quarters. The position peaked at $8.66M in Q1 2018. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

Periscope Capital reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
Periscope Capital sold 674,800 Organogenesis Holdings shares in Q4 2018, an estimated $6.84M.
Periscope Capital first reported a position in Organogenesis Holdings in Q1 2017 and held it in 7 quarters.
Periscope Capital's Organogenesis Holdings position peaked at $8.66M in Q1 2018.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Periscope Capital's 13F filing for Q4 2018, filed 13 Feb 2019.